Tagged

WASHINGTON – U.S. Senator Mike Lee (R-UT) announced today that he is leading an amicus brief urging the Supreme Court of the United States to overturn a century-old precedent that has long shielded professional baseball from the nation’s antitrust laws. Senator Lee serves as Chairman of the U.S. Senate Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights and is joined on the amicus brief by U.S. Senator Cory Booker (D-NJ), the subcommittee’s Ranking Member.

WASHINGTON – U.S. Senator Mike Lee (R-UT) introduced legislation today to cut nonsensical bureaucratic red tape preventing life-saving islet transplants for diabetic Americans. The Increase Support for Life-saving Endocrine Transplantation (ISLET) Act corrects a miscategorization of islets as drugs rather than organs – cutting through unnecessary regulations keeping critical surgeries out of reach. The legislation is sponsored by U.S. Senator Ted Budd (R-NC) and endorsed by Islets for US Collaborative, The Cure Alliance, and the Diabetes Research Institute Foundation.

WASHINGTON – U.S. Senator Mike Lee (R-UT) received unanimous support last week for the bipartisan Guarding Readiness Resources Act introduced earlier this year mandating that National Guard units receive appropriate federal reimbursements, ensuring their readiness in emergencies. The bill was cosponsored by 20 U.S. Senators and passed unanimously as an amendment to this year’s National Defense Authorization Act (NDAA).

WASHINGTON – U.S. Senator Mike Lee (R-UT) applauded the Department of Commerce’s Bureau of Industry and Security (BIS) today for rescinding a Biden-era anti-firearm rule that imposed onerous export controls on civilian firearms. Reversing this damaging policy will allow American firearm manufacturers to better compete in overseas markets.